Aditya Birla Sun Life AMC's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Aditya Birla Sun Life AMC for Q2FY24 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23(Y-o-Y) % changeQ1FY24(Q-o-Q) % changeQ2FY24
Total Income (₹crs.)387.670.78388.910.46390.69
Expenses (₹crs.)138.2511.32148.613.56153.90
Net Profit (₹crs.)191.7-7.09184.57-3.51178.09
Margin (%)49.45-3.8647.46-1.8745.58

 

REVENUE: 
Aditya Birla Sun Life AMC reported a total income of ₹390.69 crores for Q2FY24, reflecting a marginal increase of 0.46% sequentially. However, when compared to , Q2FY23 the company experienced a similarly modest rise of 0.78%.

 

EXPENSES: 
Expenses for Aditya Birla Sun Life AMC in Q2FY24 amounted to ₹153.90 crores, marking a 3.56% increase compared to the preceding quarter. On a year-on-year basis, the company's expenses increased by 11.32%.

 

NET PROFIT: 
The net profit of Aditya Birla Sun Life AMC for Q2FY24 was ₹178.09 crores, indicating a slight decline of -3.51% compared to the preceding quarter. On a year-on-year basis, the company's net profit showed a decrease of -7.09%.

 

MARGINS: 
Aditya Birla Sun Life AMC's margin in Q2FY24 was 45.58%, which represents a 1.87% decrease compared to the preceding quarter, Q1FY24. Year-on-year, the company's margin also exhibited a -3.86% change.

 

In conclusion, Aditya Birla Sun Life AMC's financial performance in Q2FY24 reflects relatively stable revenue, a marginal reduction in net profit, and a decrease in margins. 

The company operates in the asset management industry, which can be influenced by market conditions and investor sentiments. 

 

Stay tuned for more detailed updates on Aditya Birla Sun Life AMC's financial performance in the coming quarters.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions